MoSys, Inc. Reports First Quarter 2017 Financial Results
May 11, 2017 20:06 pm UTC| Business
SANTA CLARA, Calif., May 11, 2017 -- MoSys, Inc.(NASDAQ:MOSY), today reported financial results for the first quarter ended March 31, 2017. First Quarter 2017 Financial ResultsTotal net revenue for the first quarter of...
Gladstone Investment Corporation Earnings Call and Webcast Information
May 11, 2017 20:06 pm UTC| Business
MCLEAN, Va., May 11, 2017 -- Gladstone Investment Corporation (NASDAQ:GAIN) announces the following event: What:Gladstone Investment Corporation's Fourth Quarter and Year Ended March 31, 2017 Earnings Call ...
Gladstone Investment Corporation Earnings Call and Webcast Information
May 11, 2017 20:06 pm UTC| Business
MCLEAN, Va., May 11, 2017 -- Gladstone Investment Corporation (NASDAQ:GAIN) announces the following event: What:Gladstone Investment Corporation's Fourth Quarter and Year Ended March 31, 2017 Earnings Call ...
Yield10 Bioscience Announces First Quarter 2017 Financial Results
May 11, 2017 20:06 pm UTC| Business
WOBURN, Mass., May 11, 2017 -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today reported financial results for the three months ended March 31, 2017. Yield10 Bioscience kicked off the year with new branding, reflecting the...
Yield10 Bioscience Announces First Quarter 2017 Financial Results
May 11, 2017 20:06 pm UTC| Business
WOBURN, Mass., May 11, 2017 -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today reported financial results for the three months ended March 31, 2017. Yield10 Bioscience kicked off the year with new branding, reflecting the...
Selecta Biosciences Announces First Quarter 2017 Financial Results and Provides Corporate Update
May 11, 2017 20:06 pm UTC| Business
On Track to Complete Phase 2 Trial of Lead Product Candidate, SEL-212, in 2017Licensed LMB-100, a Clinical-Stage Candidate for Mesothelioma and Pancreatic Cancer, from the National Cancer Institute (NCI) Obtained Synthetic...
Selecta Biosciences Announces First Quarter 2017 Financial Results and Provides Corporate Update
May 11, 2017 20:06 pm UTC| Business
On Track to Complete Phase 2 Trial of Lead Product Candidate, SEL-212, in 2017Licensed LMB-100, a Clinical-Stage Candidate for Mesothelioma and Pancreatic Cancer, from the National Cancer Institute (NCI) Obtained Synthetic...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Biden administration tells employers to stop shackling workers with ‘noncompete agreements’
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects